Products Antibodies Polyclonal Antibodies Anti-COG2 Rabbit Polyclonal Antibody for WB, IHC-P, ELISA - Q14746

No Image

Polyclonal Antibodies

Anti-COG2 Rabbit Polyclonal Antibody for WB, IHC-P, ELISA - Q14746

Item Number : CM0027737

Price varies based on specs and customizations


Application
WB, IHC-P, ELISA
Cross Reactivity
Human, Mouse, Rat
Protein Weight
83kDa
ISO & CE icon

Shipping:

Contact us to get shipping details Enjoy On-time Dispatch Guarantee.

View Specs

Why Choose Us

Easy ordering process, quality products, and dedicated support for your business success.

Easy Process Quality Assured Dedicated Support

Core Product Specifications and Parameters

Parameter Value
Product Name COG2 Rabbit pAb
Remarks/Alias LDLC; CDG2Q; COG2
Species Human
GeneID (Human) 22796
GeneID 22796
Immunogen Recombinant fusion protein containing a sequence corresponding to amino acids 1-280 of human COG2 (NP_031383.1)
Source Rabbit
Category Polyclonal Antibodies
Application WB, IHC-P, ELISA
Cross Reactivity Human, Mouse, Rat
SWISS Q14746
Protein Weight 83kDa
Shipping Ice bag

Biological Background: COG2 Function and Localization

  • COG2, also known as LDLC or CDG2Q, is a subunit of the conserved oligomeric Golgi (COG) complex, a multi-protein tethering complex essential for intra-Golgi vesicular trafficking and maintaining Golgi structure.
  • The COG complex is composed of eight subunits (COG1-8) organized into two lobes; COG2 belongs to the lobe A subcomplex along with COG1, COG3, and COG4, and is critical for tethering vesicles to Golgi membranes.
  • COG2 is required for normal Golgi morphology and function, ensuring proper retrograde and anterograde transport of glycosylation enzymes and thereby impacting protein glycosylation.
  • Mutations in COG2 are associated with congenital disorders of glycosylation (CDG), specifically CDG type IIq (CDG2Q), characterized by defective glycosylation and severe multisystem disorders.
  • The protein localizes to the Golgi apparatus membrane and is involved in membrane protein transport pathways.
  • Alternative splicing of the COG2 gene generates multiple transcript variants, potentially modulating complex assembly or tissue-specific functions.
  • COG2 was originally identified as a low density lipoprotein receptor defect C-complementing protein (LDLC), underscoring its role in LDL receptor stability and function.

Experimental Guidance and Technical Tips

  • The immunogen covers the N-terminal region (amino acids 1-280) of human COG2, which is conserved across human, mouse, and rat, supporting expected cross-reactivity. Validation in the relevant sample system is recommended.
  • For Western blotting, the predicted molecular weight of COG2 is approximately 83 kDa. Use appropriate loading controls and optimize blocking and detection conditions.
  • In immunohistochemistry (IHC-P), antigen retrieval may be necessary due to formaldehyde fixation; consider optimizing the dilution and incubation parameters for your specific tissue type.
  • When performing ELISA, the polyclonal nature of the antibody provides robust detection sensitivity; pair with suitable secondary reagents and validate linearity.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio is your trusted one-stop partner for IVD raw-material sourcing, offering validated antibodies and ancillary reagents to accelerate diagnostic development. This anti-COG2 polyclonal antibody supports research into Golgi morphology, protein trafficking, and congenital disorders of glycosylation. Beyond this product, CamelBio provides comprehensive offerings including antibody pairs, optimized monoclonal/polyclonal antibodies, and bulk reagents, all backed by expert technical support to streamline your path from concept to clinic.

View more faqs for this product

Product Datasheet

Anti-COG2 Rabbit Polyclonal Antibody for WB, IHC-P, ELISA - Q14746


REQUEST A QUOTE

Our professional team will reply to you within one business day. Please feel free to contact us!